# FESOTERODINE FUMARATE
> **ANDA204868** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2023-01-04
## Drug
- **FDA Application Number:** ANDA204868
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FESOTERODINE FUMARATE
- **Generic name:** Fesoterodine Fumarate
- **Active ingredients:** FESOTERODINE FUMARATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ACTAVIS LABS FL INC
- **First approval:** 2023-01-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204868)
---
*AI Analytics · CC0 1.0*